Find More Contacts for aTyr Pharma
Protected Content
CEO, President
Executive Management
1 email found 1 phone number found
View contacts for aTyr Pharma to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email media@atyrpharma.com
  • Phone Number (858) 731-8389

aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of

inflammation and immunity and are in preclinical development.

The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases.

The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.

Lists Featuring This Company

West Coast Female Founded Public Companies
112 Number of Organizations • $47.4B Total Funding Amount • 1,075 Number of Investors
Pharmaceutical Companies With Less Than $1B in Revenue (Top 10K)
9,901 Number of Organizations • $285.2B Total Funding Amount • 13,249 Number of Investors
Therapeutics Public Companies With More Than $10M in Revenue
190 Number of Organizations • $93.3B Total Funding Amount • 1,882 Number of Investors
Greater San Diego Area Companies With Fewer Than 100 Employees (Top 10K)
9,484 Number of Organizations • $36.8B Total Funding Amount • 4,629 Number of Investors

Frequently Asked Questions

Where is aTyr Pharma's headquarters? aTyr Pharma is located in San Diego, California, United States.Who invested in aTyr Pharma? aTyr Pharma has 18 investors including Viking Global Investors and Redmile Group.How much funding has aTyr Pharma raised to date? aTyr Pharma has raised .When was the last funding round for aTyr Pharma? aTyr Pharma closed its last funding round on Feb 8, 2023 from a Post-IPO Equity round.Who are aTyr Pharma's competitors? Alternatives and possible competitors to aTyr Pharma may include Nutcracker TherapeuticsReata Pharmaceuticals, and AVEO Oncology.